Jatin Shah

Insider Reports History

Location
Newton, MA
Signature
/s/ Nancy Smith as Attorney-in-Fact for Jatin Shah
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jatin Shah:

Company Role Class Num Shares Value Price $ Report Date Ownership
Karyopharm Therapeutics Inc. EVP, Chief Medical Officer Common Stock 129,450 $106,149 $0.8200 17 Feb 2022 Direct

Insider Reports Filed by Jatin Shah

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KPTI Karyopharm Therapeutics Inc. 17 Feb 2022 1 -$15,833 4 EVP, Chief Medical Officer 22 Feb 2022, 15:19
KPTI Karyopharm Therapeutics Inc. 07 Feb 2022 1 -$16,805 4 EVP, Chief Medical Officer 09 Feb 2022, 16:27
KPTI Karyopharm Therapeutics Inc. 12 Jul 2021 1 -$6,470 4 EVP, Chief Medical Officer 13 Jul 2021, 18:21
KPTI Karyopharm Therapeutics Inc. 07 May 2021 1 +$199,992 4 EVP, Chief Medical Officer 11 May 2021, 08:58